Table 2.
Percent of common co-morbidities in non-cancer controls and cancer survivors (by age and cancer site)*
| Age | Non-cancer (n=100,000) |
All sites(n=457,659) | Bladder | CRC | Female Breast |
Leukemia | Lung | Oral | Prostate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHF | % with condition |
(% without) |
% with condition |
(% without) |
% with condition |
% with condition |
% with condition |
% with condition |
% with condition |
% with condition |
% with condition |
| 66–69 years |
4% | (96%) | 6% | (94%) | 6% | 7% | 3% | 7% | 10% | 6% | 4% |
| 70–74 years |
6% | (94%) | 8% | (92%) | 9% | 10% | 5% | 9% | 12% | 7% | 5% |
| 75–79 years |
8% | (92%) | 11% | (89%) | 11% | 12% | 7% | 13% | 15% | 10% | 7% |
| 80–84 years |
11% | (89%) | 15% | (85%) | 14% | 16% | 10% | 17% | 17% | 13% | 11% |
| 85+ years |
17% | (83%) | 20% | (80%) | 19% | 22% | 16% | 23% | 23% | 19% | 17% |
| COPD | |||||||||||
| 66–69 years |
9% | (91%) | 17% | (83%) | 17% | 13% | 11% | 14% | 40% | 18% | 8% |
| 70–74 years |
10% | (90%) | 18% | (82%) | 18% | 15% | 12% | 15% | 43% | 20% | 10% |
| 75–79 years |
12% | (88%) | 21% | (79%) | 20% | 18% | 13% | 18% | 43% | 20% | 11% |
| 80–84 years |
14% | (86%) | 21% | (79%) | 20% | 18% | 13% | 19% | 41% | 19% | 14% |
| 85+ years |
14% | (86%) | 19% | (81%) | 18% | 17% | 12% | 18% | 36% | 18% | 14% |
| Diabetes | |||||||||||
| 66–69 years |
20% | (80%) | 25% | (75%) | 27% | 28% | 21% | 26% | 24% | 20% | 21% |
| 70–74 years |
23% | (77%) | 27% | (73%) | 28% | 30% | 24% | 26% | 26% | 23% | 23% |
| 75–79 years |
24% | (76%) | 28% | (72%) | 29% | 29% | 25% | 28% | 26% | 26% | 24% |
| 80–84 years |
23% | (77%) | 27% | (73%) | 28% | 28% | 24% | 25% | 25% | 24% | 24% |
| 85+ years |
20% | (80%) | 23% | (77%) | 23% | 23% | 21% | 21% | 22% | 22% | 21% |
CHF = Congestive Heart Failure COPD = Chronic Obstructive Pulmonary Disease CRC=Colorectal Cancer
*
For cancer survivors, co-morbidities were identified prior to receiving a cancer diagnosis. See methods for details.